TABLE 1.
PPD-positive healthy controls | TB patients
|
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Serial no. | Apa protein
|
MTB sonicate
|
Serial no. | APA protein
|
MTB sonicate
|
|||||||||
SI (IFN-γ) | % T-cell subset
|
SI (IFN-γ) | % T-cell subset
|
|
SI (IFN-γ) | % T-cell subset
|
SI (IFN-γ) | % T-cell subset
|
||||||
CD4+ | CD8+ | CD4+ | CD8+ | CD4+ | CD8+ | CD4+ | CD8+ | |||||||
HC1 | 7.1 (1,825) | 0.40 | 0.30 | 11.3 (5,309) | 1.34 | 0.14 | P2 | 7.0 (947) | 0.07 | 0.08 | 35.0 (4,889) | 0.86 | 0.09 | |
HC2 | 3.6 (162) | 0.02 | 0.00 | 15.6 (1,127) | 0.08 | 0.01 | P7 | 5.5 (717) | 0.06 | 0.12 | 27.0 (3,995) | 0.89 | 0.06 | |
HC10 | 6.7 (746) | 0.08 | 0.15 | 30.7 (6,267) | 1.31 | 0.14 | P8 | 1.0 (6) | 0.0 | 0.0 | 37.7 (2,374) | 0.38 | 0.02 | |
HC11 | 8.8 (4,472) | 0.72 | 1.75 | 10.6 (4,374) | 1.12 | 0.08 | P9 | 5.5 (1,250) | 0.17 | 0.08 | 19.2 (6,700) | 1.35 | 0.09 | |
HC12 | 15.2 (1,708) | 0.79 | 1.50 | 10.7 (1,541) | 0.20 | 0.18 | P17 | 4.8 (192) | 0.01 | 0.03 | 17.2 (3,724) | 0.62 | 0.06 | |
HC13 | 26.9 (7,454) | 2.33 | 4.13 | 17.7 (2,510) | 0.24 | 0.13 | P18 | 3.6 (350) | 0.08 | 0.04 | 19.0 (2,606) | 0.70 | 0.22 | |
HC21 | 10.9 (1,802) | 0.32 | 0.28 | 20.8 (3,028) | 0.62 | 0.06 | P19 | 5.0 (287) | 0.03 | 0.10 | 12.6 (1,920) | 0.22 | 0.04 | |
HC22 | 5.3 (1,448) | 0.16 | 0.33 | 17.4 (3,650) | 0.37 | 0.02 | P21 | 1.0 (127) | 0.03 | 0.01 | 9.4 (1,002) | 0.16 | 0.02 | |
HC31 | 7.0 (1,237) | 0.08 | 0.00 | 36.7 (4,074) | 0.36 | 0.02 |
The SI values shown were obtained by dividing the mean cpm of triplicate cultures stimulated with antigen by that of unstimulated control wells. The IFN-γ levels shown in parentheses are in picograms/milliliter and were obtained by subtracting IFN-γ levels in culture supernatants of unstimulated cells from those of cells stimulated with antigen. % T-cell subset values are shown as percentages of each T-cell subset (either CD4+ or CD8+) after deducting the background frequencies for each subset obtained in the absence of antigen. The percentages of the CD4+ cells shown were obtained by independent staining with antibodies to human CD4.